SCHEMBL1129041

SCHEMBL1129041

Fc1cc(-c2cccc3[nH]ccc23)ccc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.51
▸ PIK3CB P42338 2/20 0.51
▸ ASH1L Q9NR48 1/20 0.50
▸ PIK3CG P48736 1/20 0.50
▸ AHR P35869 1/20 0.50
▸ CHEK1 O14757 1/20 0.46
▸ TRPA1 O75762 1/20 0.44
▸ CSNK2B P67870 1/20 0.44
▸ CSNK2A1 P68400 1/20 0.44
▸ MAPK14 Q16539 6/20 0.42
▸ ATM Q13315 1/20 0.41
▸ IDO1 P14902 1/20 0.41
▸ PIP4K2A P48426 1/20 0.41
▸ PIP4K2B P78356 1/20 0.41
▸ PIP4K2C Q8TBX8 1/20 0.41
▸ ABL1 P00519 1/20 0.39
▸ S1PR1 P21453 1/20 0.38
▸ S1PR3 Q99500 1/20 0.38
▸ HSD17B1 P14061 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085001 0.81 PIK3CD (0.53) PIK3CDPIK3CBASH1LPIK3CGCHEK1
SCHEMBL6322061 0.80 PIK3CD (0.64) PIK3CDPIK3CBASH1LPIK3CGAHR
SCHEMBL6320971 0.79 CSNK2B (0.53) PIK3CDPIK3CBASH1LPIK3CGCHEK1
SCHEMBL12420006 0.78 ASH1L (0.50) PIK3CDPIK3CBASH1LPIK3CGCHEK1
SCHEMBL6322388 0.78 ASH1L (0.59) PIK3CDPIK3CBASH1LPIK3CGAHR
SCHEMBL6322509 0.78 ASH1L (0.59) PIK3CDPIK3CBASH1LPIK3CGAHR
SCHEMBL6322152 0.77 PIK3CD (0.64) PIK3CDPIK3CBASH1LPIK3CGAHR
SCHEMBL6322590 0.76 PIK3CD (0.57) PIK3CDPIK3CBASH1LPIK3CGAHR
SCHEMBL6321495 0.75 PIK3CD (0.48) PIK3CDPIK3CBASH1LPIK3CGCHEK1
SCHEMBL7088454 0.74 PIK3CD (0.62) PIK3CDPIK3CBASH1LPIK3CGAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
CN-102046179-B Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS INC 2015-01-14 — — CN disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
CN-102046179-A Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS INC 2011-05-04 — — CN disclosed
EP-2282742-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE Infinity Pharmaceuticals, Inc. (US) 2011-02-16 — — EP disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 PIK3CD 1513/4885PIK3CB 1774/4885ASH1L 2806/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 PIK3CD 1513/4885PIK3CB 1774/4885ASH1L 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback